Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice
- PMID: 38643498
- DOI: 10.1111/apt.17951
Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice
Comment in
-
Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice. Authors' reply.Aliment Pharmacol Ther. 2024 Aug;60(3):411-412. doi: 10.1111/apt.18112. Epub 2024 Jun 14. Aliment Pharmacol Ther. 2024. PMID: 38877677 No abstract available.
Comment on
-
Upper limit of normal ALT levels in health and metabolic diseases: Pooled analysis of 423,355 individuals with bootstrap modelling.Aliment Pharmacol Ther. 2024 Apr;59(8):984-992. doi: 10.1111/apt.17914. Epub 2024 Feb 19. Aliment Pharmacol Ther. 2024. PMID: 38372477
Similar articles
-
Editorial: Redefining liver health-Personalised approach to assessment of serum ALT in clinical practice. Authors' reply.Aliment Pharmacol Ther. 2024 Aug;60(3):411-412. doi: 10.1111/apt.18112. Epub 2024 Jun 14. Aliment Pharmacol Ther. 2024. PMID: 38877677 No abstract available.
-
Liver enzymes, metabolomics and genome-wide association studies: from systems biology to the personalized medicine.World J Gastroenterol. 2015 Jan 21;21(3):711-25. doi: 10.3748/wjg.v21.i3.711. World J Gastroenterol. 2015. PMID: 25624707 Free PMC article. Review.
-
Alanine aminotransferase-old biomarker and new concept: a review.Int J Med Sci. 2014 Jun 26;11(9):925-35. doi: 10.7150/ijms.8951. eCollection 2014. Int J Med Sci. 2014. PMID: 25013373 Free PMC article. Review.
-
Raised serum transaminases: not always liver disease.Arch Dis Child. 2000 Mar;82(3):270-1. doi: 10.1136/adc.82.3.266l. Arch Dis Child. 2000. PMID: 10722416 Free PMC article. No abstract available.
-
Upper normal threshold of serum alanine aminotransferase in identifying individuals at risk for chronic liver disease.Liver Int. 2012 Jul;32(6):937-44. doi: 10.1111/j.1478-3231.2011.02749.x. Epub 2012 Jan 20. Liver Int. 2012. PMID: 22260521
References
REFERENCES
-
- Tran AN, Lim JK. Care of the patient with abnormal liver test results. Ann Intern Med. 2021;174:ITC129–ITC144.
-
- Kariv R, Leshno M, Beth‐Or A, Strul H, Blendis L, Kokia E, et al. Re‐evaluation of serum alanine aminotransferase upper Normal limit and its modulating factors in a large‐scale population study. Liver Int. 2006;26:445–450.
-
- Kwo PY, Cohen SM, Lim JK. ACG clinical guideline: evaluation of abnormal liver chemistries. Am J Gastroenterol. 2017;112(1):18–35.
-
- Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–1599.
-
- Rinella ME, Neuschwander‐Tetri BA, Siddiqui MS, Abdelmalek MF, Caldwell S, Barb D, et al. AASLD practice guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77:1797–1835.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources